Penumbra Q4: Solid Is Not Good Enough [Seeking Alpha]
Penumbra, Inc. (PEN)
Last penumbra, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.penumbrainc.com/overview/default.aspx
Company Research
Source: Seeking Alpha
The company focuses on removing clots and treating aneurysms in the neurovascular market, very large addressable markets. Despite solid growth and operating leverage, Penumbra valuations remain high as slower growth raises concerns. Looking for a helping hand in the market? Members of Value In Corporate Events get exclusive ideas and guidance to navigate any climate. Learn More » I have covered shares of Penumbra, Inc. ( NYSE: PEN on various occasions over the past year, as I believed that appeal was on the increase after shares sold off amidst the general market selloff in October. Shares have joined the momentum run in the wider stock market towards the end of the year, but sold off a bit again in the wake of the fourth quarter earnings release. Priced for near perfection, investors are not too pleased with the anticipated growth and somewhat modest margin expansion seen for 2024, as the resulting setback in the stock is not enticing enough to get involved just yet. Penum
Show less
Read more
Impact Snapshot
Event Time:
PEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PEN alerts
High impacting Penumbra, Inc. news events
Weekly update
A roundup of the hottest topics
PEN
News
- Penumbra's (PEN) New Launch to Enhance Blood Clot Removal [Yahoo! Finance]Yahoo! Finance
- Here's Why Penumbra (PEN) is a Strong Growth Stock [Yahoo! Finance]Yahoo! Finance
- Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots [Yahoo! Finance]Yahoo! Finance
- Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood ClotsPR Newswire
- Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024PR Newswire
PEN
Earnings
- 2/22/24 - Beat
PEN
Sec Filings
- 4/24/24 - Form ARS
- 4/24/24 - Form DEFA14A
- 4/24/24 - Form DEF
- PEN's page on the SEC website